"サノフィ" の関連情報検索結果

Sanofi's new CEO needs to fix drug pipeline and navigate Trump - Reuters



Sanofi's new CEO needs to fix drug pipeline and navigate Trump  Reuters

Sanofi’s stunning CEO switch—Chutes & Ladders - Fierce Biotech



Sanofi’s stunning CEO switch—Chutes & Ladders  Fierce Biotech

Paul Hudson couldn’t quite get Sanofi over the hump; PROTAC developer Arvinas appoints CEO - Endp...



Paul Hudson couldn’t quite get Sanofi over the hump; PROTAC developer Arvinas appoints CEO  Endpoints News

Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA chief Garijo - BioPharma Dive



Sanofi, looking for more ‘rigor,’ swaps CEO Hudson for ex-Merck KGaA chief Garijo  BioPharma Dive

Sanofi Tumbles After Board Shockingly Ousts CEO Paul Hudson - Investor's Business Daily



Sanofi Tumbles After Board Shockingly Ousts CEO Paul Hudson  Investor's Business Daily

A change at the top of Sanofi - statnews.com



A change at the top of Sanofi  statnews.com

Sanofi Investors Question Choice of CEO With ‘Huge Task’ Ahead - Bloomberg



Sanofi Investors Question Choice of CEO With ‘Huge Task’ Ahead  Bloomberg

Sanofi Shares Decline as Paul Hudson Removed as CEO, Making Way For Merck KGaA’s Belén Garijo - B...



Sanofi Shares Decline as Paul Hudson Removed as CEO, Making Way For Merck KGaA’s Belén Garijo  BioSpace

Sanofi: CEO Leaves With Project Rejuvenation Unfinished, But Stock Undervalued (SNY) - Seeking Alpha



Sanofi: CEO Leaves With Project Rejuvenation Unfinished, But Stock Undervalued (SNY)  Seeking Alpha

Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant - CNBC



Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant  CNBC

Meet our A Million Conversations Advisory Group - Sanofi



Meet our A Million Conversations Advisory Group  Sanofi

Press Release: Belén Garijo to become Chief Executive Officer of Sanofi - Yahoo Finance



Press Release: Belén Garijo to become Chief Executive Officer of Sanofi  Yahoo Finance

Sanofi replaces CEO Paul Hudson with outgoing Merck KGaA head - Pharmaceutical Technology



Sanofi replaces CEO Paul Hudson with outgoing Merck KGaA head  Pharmaceutical Technology

Paul Hudson out as Sanofi CEO - statnews.com



Paul Hudson out as Sanofi CEO  statnews.com

Sanofi says board has removed CEO Paul Hudson - France 24



Sanofi says board has removed CEO Paul Hudson  France 24

Sanofi selects Dr Belén Garijo as new CEO - European Pharmaceutical Review



Sanofi selects Dr Belén Garijo as new CEO  European Pharmaceutical Review

Hudson out at Sanofi, as Belén Garijo named CEO - pharmaphorum



Hudson out at Sanofi, as Belén Garijo named CEO  pharmaphorum

Sanofi ousts Paul Hudson for Merck KGaA chief after 'bumpy ride' - Fierce Pharma



Sanofi ousts Paul Hudson for Merck KGaA chief after 'bumpy ride'  Fierce Pharma

People-Powered Change: Where Employees Lead Inclusion l Sanofi - Sanofi



People-Powered Change: Where Employees Lead Inclusion l Sanofi  Sanofi

Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant - Yahoo Finance



Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant  Yahoo Finance

Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant - Reuters



Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant  Reuters

Who is Sanofi's new CEO Belén Garijo? - Reuters



Who is Sanofi's new CEO Belén Garijo?  Reuters

Does Sanofi’s CEO Overhaul And Governance Shift Change The Bull Case For Sanofi (ENXTPA:SAN)? - Y...



Does Sanofi’s CEO Overhaul And Governance Shift Change The Bull Case For Sanofi (ENXTPA:SAN)?  Yahoo Finance

Sanofi CEO: The enterprise AI shift will reshape pharma in 2026 - Fortune



Sanofi CEO: The enterprise AI shift will reshape pharma in 2026  Fortune

Sanofi Replaces CEO Hudson, Names First Woman at Helm - Bloomberg



Sanofi Replaces CEO Hudson, Names First Woman at Helm  Bloomberg

Sanofi to replace Paul Hudson with outgoing Merck KGaA chief Belén Garijo - FirstWord Pharma



Sanofi to replace Paul Hudson with outgoing Merck KGaA chief Belén Garijo  FirstWord Pharma

From Darmstadt to Paris: Belén Garijo leaves Merck to lead Sanofi after CEO exit - European Biote...



From Darmstadt to Paris: Belén Garijo leaves Merck to lead Sanofi after CEO exit  European Biotechnology Magazine

Sanofi Appoints Belén Garijo as Chief Executive Officer - Pharmaceutical Executive



Sanofi Appoints Belén Garijo as Chief Executive Officer  Pharmaceutical Executive

Pharmalittle: We're reading about Sanofi replacing its CEO, MFN drug pricing opposed by conservat...



Pharmalittle: We're reading about Sanofi replacing its CEO, MFN drug pricing opposed by conservatives, and more  statnews.com

Sanofi replaces chief Paul Hudson with Merck executive after R&D woes - Financial Times



Sanofi replaces chief Paul Hudson with Merck executive after R&D woes  Financial Times

Caprock Group LLC Makes New Investment in Sanofi $SNY - MarketBeat



Caprock Group LLC Makes New Investment in Sanofi $SNY  MarketBeat

Updated: Sanofi’s Paul Hudson out, with Belén Garijo to step in as new CEO - Endpoints News



Updated: Sanofi’s Paul Hudson out, with Belén Garijo to step in as new CEO  Endpoints News

Sanofi scraps plan to develop next-generation mRNA seasonal flu vaccine - CIDRAP



Sanofi scraps plan to develop next-generation mRNA seasonal flu vaccine  CIDRAP

Press Release: Sanofi completes the acquisition of Dynavax - Yahoo Finance



Press Release: Sanofi completes the acquisition of Dynavax  Yahoo Finance

Pharmaceutical giant Sanofi ousts CEO - WFMZ.com



Pharmaceutical giant Sanofi ousts CEO  WFMZ.com

Exclusive: Sanofi invests in China startup developing molecular glue for sickle cell disease - En...



Exclusive: Sanofi invests in China startup developing molecular glue for sickle cell disease  Endpoints News

Analysis-Sanofi’s new CEO needs to fix drug pipeline and navigate Trump By Reuters - Investing.com



Analysis-Sanofi’s new CEO needs to fix drug pipeline and navigate Trump By Reuters  Investing.com

Sanofi completes acquisition of Dynavax Technologies, triggers Nasdaq delisting - Investing.com



Sanofi completes acquisition of Dynavax Technologies, triggers Nasdaq delisting  Investing.com

Sanofi replaces CEO after R&D setbacks - Yahoo Finance Singapore



Sanofi replaces CEO after R&D setbacks  Yahoo Finance Singapore

Spotlight On: Sanofi acts swiftly to remove Paul Hudson as CEO after disappointing run of R&D rea...



Spotlight On: Sanofi acts swiftly to remove Paul Hudson as CEO after disappointing run of R&D readouts  FirstWord Pharma

Sanofi names Belén Garijo as CEO to lead R&D growth - European Medical Journal



Sanofi names Belén Garijo as CEO to lead R&D growth  European Medical Journal

Moderna vs FDA; Paul Hudson out at Sanofi; Why clinical trials are so costly; and more - Endpoint...



Moderna vs FDA; Paul Hudson out at Sanofi; Why clinical trials are so costly; and more  Endpoints News

Can New CEO Belen Garijo Reignite Sanofi's R&D Engine? - Business Chief



Can New CEO Belen Garijo Reignite Sanofi's R&D Engine?  Business Chief

Sanofi CEO Paul Hudson steps down, successor named - medwatch.com



Sanofi CEO Paul Hudson steps down, successor named  medwatch.com

As its immunology work draws attention, Sanofi also pushes forward in rare disease - statnews.com



As its immunology work draws attention, Sanofi also pushes forward in rare disease  statnews.com

Sanofi announces positive results for venglustat in type 3 Gaucher disease - PMLiVE



Sanofi announces positive results for venglustat in type 3 Gaucher disease  PMLiVE

Merck’s Belén Garijo to become CEO of Sanofi - The Pharma Letter



Merck’s Belén Garijo to become CEO of Sanofi  The Pharma Letter

Sanofi Appoints Belén Garijo as CEO - CHEManager



Sanofi Appoints Belén Garijo as CEO  CHEManager

Sanofi names Belén Garijo CEO in leadership shake-up; stock down 6% - Investing.com



Sanofi names Belén Garijo CEO in leadership shake-up; stock down 6%  Investing.com

Paul Hudson’s Legacy At Sanofi: Dupixent And Missed Opportunities - Citeline News & Insights



Paul Hudson’s Legacy At Sanofi: Dupixent And Missed Opportunities  Citeline News & Insights

Sanofi stock rating downgraded to Neutral by BofA on CEO transition - Investing.com



Sanofi stock rating downgraded to Neutral by BofA on CEO transition  Investing.com

Sanofi replaces CEO Paul Hudson, names Belén Garijo as successor (SNY:NASDAQ) - Seeking Alpha



Sanofi replaces CEO Paul Hudson, names Belén Garijo as successor (SNY:NASDAQ)  Seeking Alpha

Sanofi's genetic disorder drug shows mixed results in late-stage trials - Reuters



Sanofi's genetic disorder drug shows mixed results in late-stage trials  Reuters

Sanofi cut to “neutral” at BofA on CEO change, shares drop over 6% - Investing.com



Sanofi cut to “neutral” at BofA on CEO change, shares drop over 6%  Investing.com

Sanofi Replaces CEO Paul Hudson With Merck KGaA’s Belén Garijo - Citeline News & Insights



Sanofi Replaces CEO Paul Hudson With Merck KGaA’s Belén Garijo  Citeline News & Insights

Evommune Starts Making Case to Challenge Dominance of Sanofi’s Dupixent in Atopic Dermatitis - Me...



Evommune Starts Making Case to Challenge Dominance of Sanofi’s Dupixent in Atopic Dermatitis  MedCity News

Sanofi's Leadership Shakeup: New CEO Amid Vaccine Challenges - Global Banking & Finance Review®



Sanofi's Leadership Shakeup: New CEO Amid Vaccine Challenges  Global Banking & Finance Review®

Sanofi’s new CEO Belén Garijo gets frosty reception as Dupixent challenge awaits - Endpoints News



Sanofi’s new CEO Belén Garijo gets frosty reception as Dupixent challenge awaits  Endpoints News

Sanofi's vaccine ambitions unfazed by 'politics or sentiment in the now,' CEO Paul Hudson says - ...



Sanofi's vaccine ambitions unfazed by 'politics or sentiment in the now,' CEO Paul Hudson says  Fierce Pharma

Sanofi says board has removed CEO Paul Hudson - Northeast Mississippi Daily Journal



Sanofi says board has removed CEO Paul Hudson  Northeast Mississippi Daily Journal

Belén Garijo to lead Sanofi (NASDAQ: SNY) after April 2026 AGM - Stock Titan



Belén Garijo to lead Sanofi (NASDAQ: SNY) after April 2026 AGM  Stock Titan

Sanofi says board has removed CEO Paul Hudson - Caledonian Record



Sanofi says board has removed CEO Paul Hudson  Caledonian Record

Sanofi (SNY) Appoints New CEO Amidst Stock Challenges - GuruFocus



Sanofi (SNY) Appoints New CEO Amidst Stock Challenges  GuruFocus

Sanofi's troubled GCS inhibitor fails phase 3 Fabry trial but scores in Gaucher disease - Fierce ...



Sanofi's troubled GCS inhibitor fails phase 3 Fabry trial but scores in Gaucher disease  Fierce Biotech

Sanofi says board has removed CEO Paul Hudson - The Killeen Daily Herald



Sanofi says board has removed CEO Paul Hudson  The Killeen Daily Herald

Sanofi appoints Belén Garijo as new CEO after deciding not to renew Hudson's mandate - MSN



Sanofi appoints Belén Garijo as new CEO after deciding not to renew Hudson's mandate  MSN

Our Inclusion Strategy: A Global Commitment - Sanofi



Our Inclusion Strategy: A Global Commitment  Sanofi

Sanofi CEO Transition Highlights Strategic Reset After R&D Setbacks - TipRanks



Sanofi CEO Transition Highlights Strategic Reset After R&D Setbacks  TipRanks

Sanofi to seek approval of touted eczema drug despite mixed results - BioPharma Dive



Sanofi to seek approval of touted eczema drug despite mixed results  BioPharma Dive

Our Environmental Impact - Sanofi



Our Environmental Impact  Sanofi

Sanofi Stumbles Again in Eczema—But Plans FDA Filing for OX40 Blocker Anyway - BioSpace



Sanofi Stumbles Again in Eczema—But Plans FDA Filing for OX40 Blocker Anyway  BioSpace

Sanofi Names Belén Garijo as New CEO, Effective After April Shareholder Meeting - TipRanks



Sanofi Names Belén Garijo as New CEO, Effective After April Shareholder Meeting  TipRanks

Sanofi says board has removed CEO Paul Hudson - Indiana Gazette Online



Sanofi says board has removed CEO Paul Hudson  Indiana Gazette Online

Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant - MSN



Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant  MSN

Pfizer retains top spot in vaccine maker rankings as Sanofi's slide sparks 'code red' call - Fier...



Pfizer retains top spot in vaccine maker rankings as Sanofi's slide sparks 'code red' call  Fierce Pharma

Sanofi Stock Near 52-Week Low As Leadership Shakeup Rattles Investors - Bitget



Sanofi Stock Near 52-Week Low As Leadership Shakeup Rattles Investors  Bitget

Patient Engagement: Informing & Empowering Patients - Sanofi



Patient Engagement: Informing & Empowering Patients  Sanofi

Is Sanofi SA (SNY) One of the Best Cheap Stocks to Buy for 2026 - Yahoo Finance



Is Sanofi SA (SNY) One of the Best Cheap Stocks to Buy for 2026  Yahoo Finance

Jefferies Identifies the Key Challenge for Sanofi's New CEO - marketscreener.com



Jefferies Identifies the Key Challenge for Sanofi's New CEO  marketscreener.com

Sanofi Rare Disease Push And AI Shift Raise Long Term Questions - simplywall.st



Sanofi Rare Disease Push And AI Shift Raise Long Term Questions  simplywall.st

Sanofi names Belén Garijo as CEO - MSN



Sanofi names Belén Garijo as CEO  MSN

Leadership Change Announced for Sanofi (SNY) - GuruFocus



Leadership Change Announced for Sanofi (SNY)  GuruFocus

Sanofi says board has removed CEO Paul Hudson - Iosco County News Herald



Sanofi says board has removed CEO Paul Hudson  Iosco County News Herald

Sanofi drug, inherited from Genzyme, goes 1-for-2 in rare disease trials - BioPharma Dive



Sanofi drug, inherited from Genzyme, goes 1-for-2 in rare disease trials  BioPharma Dive

A Million Conversations: Bridging Trust Gap - Sanofi



A Million Conversations: Bridging Trust Gap  Sanofi

Berenberg Bank Remains a Buy on Sanofi (SNY) - Yahoo Finance



Berenberg Bank Remains a Buy on Sanofi (SNY)  Yahoo Finance

Sanofi (SNY) Appoints New CEO, Belén Garijo, to Lead Future Stra - GuruFocus



Sanofi (SNY) Appoints New CEO, Belén Garijo, to Lead Future Stra  GuruFocus

Sanofi Picks Belén Garijo As CEO After Hudson Exit - Finimize



Sanofi Picks Belén Garijo As CEO After Hudson Exit  Finimize

Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion - Yah...



Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion  Yahoo Finance

‘I thought we’d be faster and I was wrong’: Sanofi chief defends R&D pivot - Financial Times



‘I thought we’d be faster and I was wrong’: Sanofi chief defends R&D pivot  Financial Times

Sanofi (SNY) Appoints Belen Garijo as Incoming CEO - GuruFocus



Sanofi (SNY) Appoints Belen Garijo as Incoming CEO  GuruFocus

Sanofi Replaces CEO Paul Hudson With Merck KGaA’s Belén Garijo in Leadership Shake-Up - www.whatj...



Sanofi Replaces CEO Paul Hudson With Merck KGaA’s Belén Garijo in Leadership Shake-Up  www.whatjobs.com

Sanofi names Merck KGaA’s Garijo to replace Hudson as CEO - MSN



Sanofi names Merck KGaA’s Garijo to replace Hudson as CEO  MSN

Belén Garijo Takes Helm as Sanofi's New CEO Amid Challenges - Global Banking & Finance Review®



Belén Garijo Takes Helm as Sanofi's New CEO Amid Challenges  Global Banking & Finance Review®

Sanofi Names Belen Garijo as Chief Executive - marketscreener.com



Sanofi Names Belen Garijo as Chief Executive  marketscreener.com

Sanofi’s Board Picks Belén Garijo For A CEO Reset - Finimize



Sanofi’s Board Picks Belén Garijo For A CEO Reset  Finimize

JPM26: With pricing deal in the books, Sanofi steels against lingering policy unknowns - Fierce B...



JPM26: With pricing deal in the books, Sanofi steels against lingering policy unknowns  Fierce Biotech

Who is Belén Garijo? Paul Hudson replaced, former researcher returns as CEO of Sanofi in sudden l...



Who is Belén Garijo? Paul Hudson replaced, former researcher returns as CEO of Sanofi in sudden leadership change  Mint

Who is Sanofi's new CEO Belén Garijo? - marketscreener.com



Who is Sanofi's new CEO Belén Garijo?  marketscreener.com

Sanofi Beats on Q4 Earnings, Expects Profitable Growth in 2026 - Yahoo Finance



Sanofi Beats on Q4 Earnings, Expects Profitable Growth in 2026  Yahoo Finance